Quarterly report [Sections 13 or 15(d)]

Net Loss per Share of Common Stock (Tables)

v3.26.3
Net Loss per Share of Common Stock (Tables)
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

We have excluded the following potentially dilutive securities from the calculation of diluted net loss per share since they would have had an anti-dilutive effect:

 

    2026     2025  
    September 30,  
    2026     2025  
Shares issuable upon conversion of Series A Preferred Stock     306,574,202       -  
Shares issuable upon exercise of stock options     1,183,896       112  
Unvested restricted stock units     45,535       1,043  
Warrants to purchase shares of common stock     1,410,066       1,602,375  
Total     309,213,699       1,603,530